The chart below shows how CL performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CL sees a -1.81% change in stock price 10 days leading up to the earnings, and a +2.07% change 10 days following the report. On the earnings day itself, the stock moves by +0.00%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Net Sales Increase: Net sales were up 4.5%.
Organic Sales Increase: Organic sales were up 8.5%.
Volume Growth Achievement: We delivered volume growth in all six divisions for the second straight quarter with 3% growth in developed markets and 4.6% growth in emerging markets.
Gross Profit Growth: Gross profit dollar growth was strong, driven by improved gross margin expansion.
Oral Care Growth Opportunities: We continue to see strong growth opportunities in our Oral Care business, particularly in Latin America.
Negative
Sales Growth Analysis: Net sales were up 4.5%, but organic sales growth was only 8.5%, indicating a reliance on pricing rather than volume growth.
Shipment Timing Impact: Despite a strong performance, there were significant shipment timing issues that pushed some orders from Q3 to Q4, affecting overall sales figures.
Gross Margin Decline: The company experienced a decline in gross margin due to inflationary pressures, which could impact profitability moving forward.
Organic Sales Slowdown: There was a noted slowdown in organic sales growth in certain markets, particularly in North America, which may affect future performance.
Challenging Competitive Landscape: The competitive environment remains challenging, with peers performing strongly, suggesting potential market share losses for the company.
Colgate-Palmolive (CL) Q3 2024 Earnings Call Transcript
CL.N
3.79%